Clinical Trials Logo

Localized Breast Cancer clinical trials

View clinical trials related to Localized Breast Cancer.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT05296317 Recruiting - Clinical trials for Localized Breast Cancer

Evaluation and Modeling of the Effect of G-CSF on the Evolution of Polynuclear Neutrophils During Dense Dose Epirubicin-Cyclophosphamide Regeneration

EMEG-ECDD
Start date: September 2, 2022
Phase: N/A
Study type: Interventional

Patients including of localized breast cancer will require chemotherapy treatment with epirubicin - cyclophosphamide (EC) followed by treatment with docetaxel or paclitaxel. In addition to this chemotherapy, the investigator will prescribe injections of granulocyte growth factors (G-CSF), to stimulate the growth of white blood cells. Patients will be randomized to either a peg-G-CSF arm or a G-CSF arm, prescribed at different times. The aim is to determine whether one of the two treatment regimens best limits the risk of a decrease in white blood cells

NCT ID: NCT04680715 Recruiting - Clinical trials for Localized Breast Cancer

Per-Operative Radiotherapy by Papillon +TM in Localized Breast Cancer

RPOS+2
Start date: July 16, 2021
Phase: N/A
Study type: Interventional

Phase II study; open recruitment, multicentrique. The aim of this clinical research is to evaluate faisability and toxicity of the per-operative radiotherapy using PAPILLON + TM device for localized breast cancers patients over 65 years.

NCT ID: NCT00651417 Recruiting - Clinical trials for Localized Prostate Cancer

Use of Organic Germanium or Placebo for the Prevention of Radiation Induced Fatigue

Start date: April 2005
Phase: Phase 2
Study type: Interventional

Participants will be diagnosed with localized prostate or breast cancer and be scheduled to undergo external beam radiation therapy. Participants will either receive a placebo or organic germanium to be taken 5 times a day starting the day of their first radiation and continuing through the 1 month follow-up visit. Weekly Quality of life forms will be completed through the one month follow up visit and then at the 3 month follow up visit. Labs will be done prior to the start of treatment, at the end of treatment and at the one and three month follow-up visits.